chr3-121632518-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_005335.6(HCLS1):c.1054C>T(p.Leu352Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000571 in 1,612,378 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005335.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HCLS1 | NM_005335.6 | c.1054C>T | p.Leu352Phe | missense_variant | 12/14 | ENST00000314583.8 | |
HCLS1 | NM_001292041.2 | c.943C>T | p.Leu315Phe | missense_variant | 11/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HCLS1 | ENST00000314583.8 | c.1054C>T | p.Leu352Phe | missense_variant | 12/14 | 1 | NM_005335.6 | P1 | |
HCLS1 | ENST00000428394.6 | c.943C>T | p.Leu315Phe | missense_variant | 11/13 | 2 | |||
HCLS1 | ENST00000473883.5 | n.1857C>T | non_coding_transcript_exon_variant | 7/9 | 2 | ||||
HCLS1 | ENST00000495491.5 | c.*369C>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151094Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000966 AC: 24AN: 248372Hom.: 1 AF XY: 0.000134 AC XY: 18AN XY: 134550
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461284Hom.: 1 Cov.: 36 AF XY: 0.0000853 AC XY: 62AN XY: 726956
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151094Hom.: 0 Cov.: 31 AF XY: 0.0000271 AC XY: 2AN XY: 73784
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at